Cargando…

Pharmacokinetics of Myo-Inositol in a Wistar Rat Animal Model

Myo-inositol is the most popular inositol in living organisms, where it is present as a sugar alcohol, in a free form, and can also be described as a lipid. The aim of this study was to check the concentration change of a myo-inositol solution from the time of oral administration and over a 48 h per...

Descripción completa

Detalles Bibliográficos
Autores principales: Antonowski, Tomasz, Osowski, Adam, Szczesny, Damian, Szablińska-Piernik, Joanna, Juśkiewicz, Jerzy, Lahuta, Lesław, Rynkiewicz, Andrzej, Wojtkiewicz, Joanna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570207/
https://www.ncbi.nlm.nih.gov/pubmed/36232547
http://dx.doi.org/10.3390/ijms231911246
_version_ 1784810049172930560
author Antonowski, Tomasz
Osowski, Adam
Szczesny, Damian
Szablińska-Piernik, Joanna
Juśkiewicz, Jerzy
Lahuta, Lesław
Rynkiewicz, Andrzej
Wojtkiewicz, Joanna
author_facet Antonowski, Tomasz
Osowski, Adam
Szczesny, Damian
Szablińska-Piernik, Joanna
Juśkiewicz, Jerzy
Lahuta, Lesław
Rynkiewicz, Andrzej
Wojtkiewicz, Joanna
author_sort Antonowski, Tomasz
collection PubMed
description Myo-inositol is the most popular inositol in living organisms, where it is present as a sugar alcohol, in a free form, and can also be described as a lipid. The aim of this study was to check the concentration change of a myo-inositol solution from the time of oral administration and over a 48 h period in Wistar-type rats. All rats received 2 g/kg of inositol as a solution in distilled water by oral gavage. Estimated parameters were based on the serum concentration of myo-inositol observed in nine individual rats with regard to time. Observations were described as a one-compartment pharmacokinetic model with first-order absorption and zero-order endogenous input of checked inositol. The highest myo-inositol concentration was observed in the first hour after oral administration in the serum of all tested rats. Then, the concentration began decreasing immediately after the maximal peak. The inositol concentration continued to decrease, but after 24 h its level was still higher than before the administration. The plasma profile of the myo-inositol concentration showed a rapid decline over time, possibly due to the metabolism of this compound.
format Online
Article
Text
id pubmed-9570207
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-95702072022-10-17 Pharmacokinetics of Myo-Inositol in a Wistar Rat Animal Model Antonowski, Tomasz Osowski, Adam Szczesny, Damian Szablińska-Piernik, Joanna Juśkiewicz, Jerzy Lahuta, Lesław Rynkiewicz, Andrzej Wojtkiewicz, Joanna Int J Mol Sci Article Myo-inositol is the most popular inositol in living organisms, where it is present as a sugar alcohol, in a free form, and can also be described as a lipid. The aim of this study was to check the concentration change of a myo-inositol solution from the time of oral administration and over a 48 h period in Wistar-type rats. All rats received 2 g/kg of inositol as a solution in distilled water by oral gavage. Estimated parameters were based on the serum concentration of myo-inositol observed in nine individual rats with regard to time. Observations were described as a one-compartment pharmacokinetic model with first-order absorption and zero-order endogenous input of checked inositol. The highest myo-inositol concentration was observed in the first hour after oral administration in the serum of all tested rats. Then, the concentration began decreasing immediately after the maximal peak. The inositol concentration continued to decrease, but after 24 h its level was still higher than before the administration. The plasma profile of the myo-inositol concentration showed a rapid decline over time, possibly due to the metabolism of this compound. MDPI 2022-09-24 /pmc/articles/PMC9570207/ /pubmed/36232547 http://dx.doi.org/10.3390/ijms231911246 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Antonowski, Tomasz
Osowski, Adam
Szczesny, Damian
Szablińska-Piernik, Joanna
Juśkiewicz, Jerzy
Lahuta, Lesław
Rynkiewicz, Andrzej
Wojtkiewicz, Joanna
Pharmacokinetics of Myo-Inositol in a Wistar Rat Animal Model
title Pharmacokinetics of Myo-Inositol in a Wistar Rat Animal Model
title_full Pharmacokinetics of Myo-Inositol in a Wistar Rat Animal Model
title_fullStr Pharmacokinetics of Myo-Inositol in a Wistar Rat Animal Model
title_full_unstemmed Pharmacokinetics of Myo-Inositol in a Wistar Rat Animal Model
title_short Pharmacokinetics of Myo-Inositol in a Wistar Rat Animal Model
title_sort pharmacokinetics of myo-inositol in a wistar rat animal model
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570207/
https://www.ncbi.nlm.nih.gov/pubmed/36232547
http://dx.doi.org/10.3390/ijms231911246
work_keys_str_mv AT antonowskitomasz pharmacokineticsofmyoinositolinawistarratanimalmodel
AT osowskiadam pharmacokineticsofmyoinositolinawistarratanimalmodel
AT szczesnydamian pharmacokineticsofmyoinositolinawistarratanimalmodel
AT szablinskapiernikjoanna pharmacokineticsofmyoinositolinawistarratanimalmodel
AT juskiewiczjerzy pharmacokineticsofmyoinositolinawistarratanimalmodel
AT lahutalesław pharmacokineticsofmyoinositolinawistarratanimalmodel
AT rynkiewiczandrzej pharmacokineticsofmyoinositolinawistarratanimalmodel
AT wojtkiewiczjoanna pharmacokineticsofmyoinositolinawistarratanimalmodel